Task: Answer the MCQ question.
Question: Which drug exhibits a -26.772% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Cn1nccc1C(=O)NC(=S)Nc1cc(Cl)cc(Cl)c1
b.) CCCCN(C)C(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
c.) COc1cccc(CN(C)C(=O)CN2C(=O)NC3(CCCc4ccccc43)C2=O)c1
Answer: b. CCCCN(C)C(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C)C(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
CCCCN(C)C(=O)C1CCCN(S(=O)(=O)c2ccc3c(c2)CC(C)N3C(=O)C2CC2)C1
N-butyl-1-[[1-(cyclopropanecarbonyl)-2-methyl-2,3-dihydroindol-5-yl]sulfonyl]-N-methylpiperidine-3-carboxamide